Approximately 49,896 bottles of Valganciclovir (450 mg) and Valacyclovir (1 gram) prescription tablets are being recalled because they were exposed to high temperatures during shipping at an airport or in cargo. This exposure to excessive heat could potentially reduce the effectiveness of the medication or cause the drug to break down. Affected products were distributed nationwide in the United States after initially being sent to New Jersey. Consumers who have these medications should contact their healthcare provider or pharmacist for guidance on obtaining a safe replacement.
The medications were exposed to temperatures higher than the recommended storage limits during transit. This 'temperature abuse' can compromise the chemical stability and potency of the drugs, meaning they may not work as intended to treat viral infections.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.